Farmas USA

tampoco es para pedir perdón;) Es una noticia muy importante, aunque esperada.
"The shares have rise 12.57% since it confirmed exclusive talks with J&J on Dec. 21 but are more than 50% higher since takeover speculation first surfaced in late November"

Lo que es interesante es el deal que han hecho. Había un problema y es que Actelion era muy cara para cualquier farma ya que se ha convertido en la biotech mas grande de eruropa. Lo que han hecho es un spin out del R&D y será una nueva compañía de biotech liderada por el actual CEO de Actelion.

Johnson & Johnson (JNJ) said Thursday it will purchase Swiss biotech Actelion Pharmaceuticals (ALIOY) for $30 billion and plans to spin out the company's research and development unit into a separate business.

J&J will pay $280 per share for the Allschwil, Switzerland-based group, which is the Swiss franc equivalent of Sfr280.08 per share, the companies said in a statement. Once the R&D unit is spun out, Actelion shareholders will receive a one-for-one holding in the new company as a dividend. The deal was unanimously approved by both boards, the statement said.

Hola Framus,

¿conocéis la pharma Endo investments?

¿Cómo la veis?

Gracias

BMY

Bristol-Myers Squibb Cuts Guidance on Cancer Drug Problems

http://www.wsj.com/articles/bristol-myers-squibb-cuts-guidance-on-cancer-drug-problems-1485432039

Otra compra hoy, aunque la empresa adquirida es privada, pero por animar el sector: Celgene y Delinia

PD: pues lo sabríais los de dentro del sector, porque por aquí no parece que ninguno nos hubiéramos enterado. Si avisas de estas cosas les podemos sacar partido.

Delinia Delivers An Exciting Autoimmune Therapy To Celgene
https://lifescivc.com/2017/01/delinia-delivers-exciting-autoimmune-therapy-celgene/

Celgene splashes out $300M on Delinia autoimmune biotech buy

http://www.fiercebiotech.com/biotech/celgene-splashes-out-300m-delinia-autoimmune-biotech-buy

CLLS (CAR-T)

Two Infants Treated with Universal Immune Cells Have Their Cancer Vanish

Doctors in London say they have cured two babies of leukemia in the world’s first attempt to treat cancer with genetically engineered immune cells from a donor.

Although the cases drew wide media attention in Britain, some researchers said that because the London team also gave the children standard chemotherapy, they failed to show the cell treatment actually cured the kids. “There is a hint of efficacy but no proof

https://www.technologyreview.com/s/603502/two-infants-treated-with-universal-immune-cells-have-their-cancer-vanish/

Investigators detail some of the hopes – and fears – behind Cellectis’ off-the-shelf CAR-T

https://endpts.com/investigators-detail-some-of-the-hopes-and-fears-behind-cellectis-off-the-shelf-car-t

Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells

http://stm.sciencemag.org/content/9/374/eaaj2013

supongo que te refieres a ENDO INTERNACIONAL, ENDP.

Sobrevendida en diario, el MACD apuntando maneras a que la peor parte pudiera haber pasado pero todavia en terreno bearish.

Seguro que te llama que esta en minimos de 52 semanas ...

bueno, aqui el grafico mensual ... telita ...

IRWD

FDA Approves 72 mcg Dose of LINZESS for Adults with CIC
http://seekingalpha.com/news/3237786-fda-oks-new-linzess-dose-cic-patients

Estreno el pre con unas cuantas a largo a 14,60 sin especial convicción por si suena la flauta.

Ya Se puso aquí la noticia de que J&J estaba pensando en comprar actelion hace tiempo